Retatrutide in the Philippines
Triple‑target precision: appetite control, metabolic boost, and research‑grade guidance for the Philippines.
What is Retatrutide?
Retatrutide is a next-generation peptide that activates GLP-1, GIP, and GCGR receptors. This triple-agonist approach supports appetite control, glucose balance, and increased energy expenditure for advanced metabolic health.
Appetite & Satiety
Promotes fullness and reduces cravings for better meal consistency.
Glucose & Metabolic Balance
Helps regulate blood sugar and supports smoother energy levels.
Energy Expenditure
GCGR activation may increase calorie burn and support body recomposition.
Refinetide (Retatrutide)
Our retatrutide-equivalent research peptide. Designed for comprehensive metabolic support, appetite control, and enhanced energy turnover.
Also explore: Trimtide
Tirzepatide-based dual-agonist (GLP-1/GIP) for appetite and metabolic balance. Useful for comparison and study planning.
Access in the Philippines
STEP 01
Eligibility & Screening
Initial intake form and health history review to confirm fit and safety.
STEP 02
Onboarding & Starter Plan
Mixing/dosing guide, storage tips, and first-week routine. Advice for comfort and adherence.
STEP 03
Lifestyle Integration
Regular check-ins for progress. Combine with nutrition, resistance training, sleep, and stress care for best results.
Ready to personalize?
Start with our quick questionnaire to map your goals and timeline.
Start Weight-Loss Questionnaire →Transparent Pricing
Studio Wellness access starts at ₱3,900 for 8 weeks of research supply.
Refinetide (Retatrutide)
Estimated potential loss
over 6–12 months of consistent use
Plan Your Journey
Community & Learning
Potential Side Effects
GI Effects
Nausea, vomiting, diarrhea/constipation—often transient during early weeks.
Appetite Change
Fullness and reduced cravings are expected; adjust meal size and protein.
Fatigue
Mild tiredness or headache may occur while adapting; hydration and sleep help.
Possible Increased Heart Rate
GCGR activation may cause a slight increase in resting heart rate for some individuals.
Safety Notes
- Start low, escalate slowly with a licensed clinician.
- Expect GI effects early — often transient.
- Monitor labs and any medications that affect glucose or heart rate.
- This guide is educational. Individual risk varies — consult your physician before starting, stopping, or changing any protocol.
Compounded products are not approved nor evaluated for safety, effectiveness, or quality by the FDA.
Take Your Next Step
Explore Refinetide, learn from our guides, and use the tools to plan your path with clarity.